Here's the live share price of Indoco Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Indoco Remedies has gained 1.26% CAGR. Over the past year, the corresponding return has been -20.35%.
Indoco Remedies’s current P/E of -24.61x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
---|---|---|---|---|---|---|---|
Indoco Remedies | 8.07 | 2.10 | 4.62 | 36.72 | -20.35 | -5.07 | 1.26 |
Sun Pharmaceutical Industries | 1.67 | -0.74 | -1.73 | -5.03 | -13.17 | 22.82 | 25.92 |
Divi's Laboratories | 0.43 | -1.79 | -7.35 | 6.82 | 11.03 | 18.72 | 13.53 |
Cipla | -0.28 | -0.33 | 3.71 | 4.44 | -6.69 | 14.64 | 15.70 |
Torrent Pharmaceuticals | -1.10 | -2.72 | 9.28 | 16.13 | 2.96 | 33.93 | 20.15 |
Dr. Reddy's Laboratories | 0.52 | 3.73 | -0.61 | 13.95 | -1.15 | 16.94 | 6.31 |
Mankind Pharma | -1.64 | 3.88 | 9.08 | 18.13 | 4.58 | 21.69 | 12.50 |
Zydus Lifesciences | -0.57 | 4.75 | 7.77 | 15.69 | -6.93 | 42.16 | 21.26 |
Lupin | 2.60 | 3.02 | 4.40 | 1.91 | -10.64 | 46.79 | 14.35 |
Abbott India | -0.85 | -4.90 | -2.43 | 2.84 | 7.47 | 21.30 | 13.54 |
Alkem Laboratories | 2.66 | 2.12 | 13.49 | 13.40 | -12.19 | 18.95 | 13.98 |
Aurobindo Pharma | 4.16 | 0.37 | -1.39 | -1.69 | -29.51 | 28.16 | 6.17 |
Glenmark Pharmaceuticals | -4.41 | 3.19 | 23.20 | 42.38 | 18.91 | 76.49 | 32.85 |
Anthem Biosciences | 5.89 | 7.84 | 18.23 | 18.23 | 18.23 | 5.74 | 3.41 |
Laurus Labs | -0.51 | 3.09 | 35.04 | 53.43 | 77.96 | 20.69 | 25.98 |
Biocon | -2.53 | -2.59 | 0.62 | 6.24 | -5.53 | 6.94 | -4.31 |
GlaxoSmithKline Pharmaceuticals | -3.46 | -1.94 | -15.89 | 1.60 | -2.30 | 24.69 | 9.19 |
Cohance Lifesciences | -2.30 | 7.56 | -2.57 | -14.86 | -16.33 | 28.11 | 20.30 |
Ipca Laboratories | -0.07 | -5.18 | -3.23 | -0.19 | -9.85 | 15.26 | 4.10 |
Gland Pharma | 4.39 | 0.78 | 13.75 | 27.92 | 7.57 | -3.99 | 1.77 |
Over the last one year, Indoco Remedies has declined 20.35% compared to peers like Sun Pharmaceutical Industries (-13.17%), Divi's Laboratories (11.03%), Cipla (-6.69%). From a 5 year perspective, Indoco Remedies has underperformed peers relative to Sun Pharmaceutical Industries (25.92%) and Divi's Laboratories (13.53%).
Day | SMA | EMA |
---|---|---|
5 | 290.84 | 295.94 |
10 | 283.75 | 290.11 |
20 | 281.61 | 287.8 |
50 | 300.86 | 290.17 |
100 | 283.73 | 287.12 |
200 | 280.32 | 289.45 |
In the latest quarter, Indoco Remedies remained same as its previous close in promoter holding, while DII stake increased to 18.96%, FII holding fell to 1.22%, and public shareholding moved down to 20.82% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
---|---|---|---|
Quant Small Cap Fund | 41,99,230 | 0.39 | 111.95 |
DSP Healthcare Fund | 32,33,474 | 2.77 | 86.2 |
Nippon India Small Cap Fund | 25,94,559 | 0.11 | 69.17 |
Franklin India Smaller Companies Fund | 20,25,592 | 0.41 | 54 |
Nippon India Pharma Fund | 18,34,924 | 0.59 | 48.92 |
HDFC Capital Builder Value Fund - Regular Plan | 8,82,298 | 0.33 | 23.52 |
HDFC Multi Cap Fund | 6,61,080 | 0.1 | 17.62 |
Tata India Pharma & HealthCare Fund | 4,28,635 | 0.87 | 11.43 |
Motilal Oswal BSE Healthcare ETF | 885 | 0.07 | 0.02 |
Date Time | Announcement |
---|---|
Sep 12, 2025, 9:14 PM IST | Indoco Remedies - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Sep 11, 2025, 6:25 AM IST | Indoco Remedies - Shareholder Meeting / Postal Ballot-Outcome of AGM |
Aug 30, 2025, 3:57 PM IST | Indoco Remedies - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements |
Aug 29, 2025, 6:09 AM IST | Indoco Remedies - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Aug 14, 2025, 9:49 PM IST | Indoco Remedies - Business Responsibility and Sustainability Reporting (BRSR) |
Indoco Remedies Ltd. is a Public Limited Listed company incorporated on 23/08/1947 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L85190MH1947PLC005913 and registration number is 005913. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 1518.19 Cr. and Equity Capital is Rs. 18.45 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Indoco Remedies is ₹299.15 as on Sep 17, 2025.
The Indoco Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Indoco Remedies is ₹2,759.60 Cr as on Sep 17, 2025.
Today’s highest and lowest price of Indoco Remedies are ₹312.55 and ₹298.50.
The 52-week high/low is the highest and lowest price at which Indoco Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Indoco Remedies is ₹383.55 and 52-week low of Indoco Remedies is ₹190.00 as on Sep 17, 2025.
The Indoco Remedies has shown returns of -1.64% over the past day, 2.1% for the past month, 4.62% over 3 months, -20.35% over 1 year, -5.07% across 3 years, and 1.26% over 5 years.
P/E ratio of and PB ratio of Indoco Remedies are -24.61 and 2.53 on Sep 17, 2025. While the company gives a dividend yield of 0.07 per annum.